Assessment of anti-thrombotic effects of conventional anti-thrombotic therapy using total thrombus-formation analysis system in transcatheter aortic valve replacement
Not Applicable
- Conditions
- Aortic stenosis
- Registration Number
- JPRN-UMIN000041165
- Lead Sponsor
- Teikyo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who met the following criteria were excluded from this study; 1) TAVI using alternative access, 2) patients who cannot take anti-thrombotic therapy prior to TAVI, 3) TAVI needed more than two valve, 4) TAVI needed emergent surgical conversion, 5) new-onset atrial fibrillation, 6) TAVI in SAV, 7) patients refused to participate this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti-thrombotic abilities
- Secondary Outcome Measures
Name Time Method Mortality, bleeding events, thrombotic events